Trademark Search in Canada

DNA HELIX DESIGN

View On IC.GC.CA

ABANDONED SECTION 40(3)

on 30 Jan 2019

Last Applicant/ Owned by

DIMENSION THERAPEUTICS INC.

840 Memorial Drive, 4th FloorCambridge, MA 02139

Serial Number

1762697 filed on 11^th Jan 2016

Correspondent Address

BORDEN LADNER GERVAIS LLP

ATTN: INTELLECTUAL PROPERTY DEPARTMENT1000 DE LA GAUCHETIERE STREET WESTSUITE 900MONTREAL

QUEBEC

H3B5H4

DNA HELIX DESIGN

Trademark usage description

chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, Read More

Vienna Information

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 5 . 1

One polygonUn polygone

26 . 5 . 14

Polygons containing representations of human beings or parts of the human bodyPolygones contenant la représentation d'êtres humains ou de parties du corps humain

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

Classification Information

Class [001]
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy.

Classification kind code

Class [005]
Pharmaceutical preparations for the treatment of genetic diseases and disorders of the liver, gallbladder, and pancreas; Pharmaceutical preparations for the treatment of liver, hepatological, namely, diseases and disorders of the liver, gallbladder, and pancreas, cardiovascular, endocrine, gastrointestinal, immunological disorders, namely, autoimmune diseases, hypersensitivities, and immune deficiency, acute inflammation and chronic inflammation, menopausal, metabolic diseases, namely, diabetes, hypoglycaemia, gout, and anorexia, autoimmune, musculoskeletal, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, ophthalmologic, respiratory, urogenital, urological, hematologic, and fungal; pharmaceutical preparations for the treatment of pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders of the liver, gallbladder, and pancreas; Gene therapy and phrophylaxis products for the treatment of liver, hepatological, namely, diseases and disorders of the liver, gallbladder, and pancreas, cardiovascular, endocrine, gastrointestinal, immunological disorders, namely autoimmune diseases, hypersensitivities, and immune deficiency, acute inflammation and chronic inflammation, menopausal, metabolic diseases, namely, diabetes, hypoglycaemia, gout, and anorexia, autoimmune, musculoskeletal, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, ophthalmologic, respiratory, urogenital, urological, hematologic, and fungal.

Classification kind code

Class [042]
Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; and companion diagnostics and assays services in the field of gene therapy design and delivery.

Classification kind code

Class [044]
Providing medical services, namely, gene therapy design and delivery services in the field of genetic diseases and disorders of the liver, gallbladder, and pancreas, providing medical services, namely, gene therapy design and delivery services in the field of liver, hepatological, namely, diseases and disorders of the liver, gallbladder, and pancreas, cardiovascular, endocrine, gastrointestinal, immunological disorders, namely, autoimmune diseases, hypersensitivities, and immune deficiency, acute inflammation and chronic inflammation, menopausal, metabolic diseases, namely, diabetes, hypoglycaemia, gout, and anorexia, autoimmune, musculoskeletal, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, ophthalmologic, respiratory, urogenital, urological, hematologic, and fungal.

Classification kind code

Mark Details

Serial Number

1762697

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 130 on 6^th Jul 2017	Note to file
Submitted for opposition 110 on 15^th May 2017	Proposed Opposition
Submitted for opposition 42 on 15^th Mar 2017	Advertised
Submitted for opposition 26 on 23^rd Feb 2017	Approved
Submitted for opposition 27 on 6^th Jan 2017	Approval Notice Sent
Submitted for opposition 22 on 27^th Jun 2016	Search Recorded
Submitted for opposition 20 on 27^th Jun 2016	Examiner's First Report
Submitted for opposition 31 on 12^th Jan 2016	Formalized
Submitted for opposition 30 on 11^th Jan 2016	Filed
Submitted for opposition 1 on 11^th Jan 2016	Created

DNA HELIX DESIGN

Classification Information

Class [001]Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy.

Classification kind code

Classification kind code

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [001]
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy.